[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.145.218.90. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
December 1983

2.5% v 10% Phenylephrine in Maintaining Mydriasis During Cataract Surgery

Author Affiliations

From the Jules Stein Eye Institute and the Department of Ophthalmology, UCLA School of Medicine.

Arch Ophthalmol. 1983;101(12):1903-1906. doi:10.1001/archopht.1983.01040020905014
Abstract

• A 10% viscous solution of phenylephrine hydrochloride was more effective than a 2.5% aqueous solution of phenylephrine hydrochloride in maintaining mydriasis during extracapsular cataract surgery. The pupil area after nucleus expression was 57% larger with the stronger phenylephrine concentration. The difference in pupil area was greater in darkly pigmented irides (114%) than in moderately pigmented (70%) or lightly pigmented irides (12%). Mean BP elevations following phenylephrine administration were not higher in the group receiving the 10% solution than in the group receiving the 2.5% solution. In darkly pigmented irides, a 10% viscous solution of phenylephrine hydrochloride is more effective than a 2.5% concentration in maintaining mydriasis during cataract surgery.

References
1.
Haddad NJ, Moyer NJ, Riley FC Jr:  Mydriatic effect of phenylephrine hydrochloride . Am J Ophthalmol 1970;70:729-733.
2.
Neuhaus RW, Hepler RS:  Mydriatic effect of phenylephrine 10% (aq) versus phenylephrine 2.5% (aq) . Ann Ophthalmol 1980;12:1159-1160.
3.
Smith RB, Read S, Oczypok PM:  Mydriatic effect of phenlyephrine . Eye Ear Nose Throat J 1976;55:36-37.
4.
Duffin RM, Camras CB, Gardner SK, et al:  Inhibitors of surgically-induced miosis . Ophthalmology 1982;89:966-979.Article
5.
Fraunfelder FT, Scafidi AF:  Possible adverse effects from topical ocular 10% phenylephrine . Am J Ophthalmol 1978;85:447-453.
6.
Vaughan RW:  Ventricular arrhythmias after topical vasoconstrictors . Anesth Analg 1973; 52:161-165.
7.
Solosko D, Smith RB:  Hypertension following 10 percent phenylephrine ophthalmic . Anesthesiology 1972;36:187-189.Article
8.
Robertson D:  Contraindication to the use of ocular phenylephrine in idiopathic orthostatic hypotension . Am J Ophthalmol 1979;87:819-822.
9.
Stevenson CE, Mathewson HS:  Hypertensive reactions to phenylephrine eyedrops in patients with sympathetic denervation . Am J Ophthalmol 1978;85:862-868.
10.
Wilensky JT, Woodward HJ:  Acute systemic hypertension after conjunctival instillation of phenylephrine hydrochloride . Am J Ophthalmol 1973;76:156-157.
11.
Lansche RK:  Systemic reactions to topical epinephrine and phenylephrine . Am J Ophthalmol 1966;61:95-98.
12.
McReynolds WU, Havener WH, Henderson JW:  Hazards of use of sympathomimetic drugs in ophthalmology . Arch Ophthalmol 1956;56:176-179.Article
13.
Wellwood M, Goresky GV:  Systemic hypertension associated with topical administration of 2.5% phenylephrine HCl . Am J Ophthalmol 1982; 93:369-370.
14.
Gambill HD, Ogle KN, Kearns TP:  Mydriatic effect of four drugs determined with pupillograph . Arch Ophthalmol 1967;77:740-746.Article
15.
Obianwu HO, Rand MJ:  The relationship between the mydriatic action of ephedrine and the colour of the iris . Br J Ophthalmol 1965; 49:264-270.Article
16.
Barbee RF, Smith WO Jr:  A comparative study of mydriatic and cycloplegic agents . Am J Ophthalmol 1957;44:617-622.
17.
Angenent WJ, Koelle GB:  A possible enzymatic basis for the differential action of mydriatics on light and dark irides . J Physiol 1953;119:102-117.
×